Western blot assays revealed that WNT/β-catenin signaling was attenuated after increasing the m6A-modificated level of FGFR4 mRNA in rSKBR3 breast cancer cells (Supplementary Fig. 5d). This evidence concerns the gene FGFR4 and breast cancer.